Sussex Research Laboratories Inc. to Exhibit at the 8th Annual OPT Congress

Sussex Research Laboratories Inc., leading GalNAc and carbohydrate targeting ligand specialist, is excited to announce sponsorship of the 8th Annual OPT Congress - Oligonucleotide & Precision Therapeutics!

For over 25 years, we have enabled application of complex carbohydrate systems, including GalNAc and glycopeptides, in drug discovery, drug delivery, drug targeting, glycoconjugate vaccine development, immunotherapy, therapeutic enhancement and diagnostic/bio-analytical assay development. Visit us at booth 16 from March 13-14, 2023 in Boston, Massachusetts, USA!